← Evidence map

ArticleJournal of diabetes science and technology2015

Biosimilar Insulin and Costs: What Can We Expect?

Lutz HeinemannPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 26350722